Posts by Sandra Ansanay-Alex
Givaudan and Nestlé: a Challenging First Semester for the two Swiss Health Valley Powerhouses
Two of Switzerland’s biggest names in industry unveiled their half-year results on Thursday, and the stock market did not respond well. Givaudan and Nestlé, both based in the Lake Geneva region, saw their share prices fall sharply at the opening bell, driven by disappointing figures despite some encouraging signs. At Givaudan, the flavour and fragrance…
Read MoreLifeSpan Summit
The LifeSpan Summit is taking place from 14 to 16 October 2026 in Malaga, Spain The LifeSpan Summit is the premier customer-driven, business-led global gathering dedicated to transforming longevity innovation into real-world impact. Designed as an active environment for learning, exchange, and co-creation, the Summit brings together cross-sector leaders to explore the tools, business models, and technological breakthroughs shaping the future of…
Read MoreHilo Raises $19 Million and Launches Wearable Blood Pressure Monitor in the US
Hilo has launched Hilo Core, a wearable system designed to give people long-term blood pressure insights instead of one-off cuff readings. The company, based in Neuchâtel, Switzerland, is bringing the device to the US market starting today, available via Hilo.com and Amazon. Hilo Core pairs a lightweight wrist band with a mobile app and an…
Read MoreImmitra Bio Closed a CHF 2.4 Million Pre-Seed Financing Round
The ETHZ spinoff and Geneva-based company aims to replace complex stem cell transplantation procedures with a single injection, making potentially curative therapies more accessible to patients worldwide. CHF 2.25 million was provided by venture capital and private investors, with an additional CHF 150k secured through non-dilutive funding sources. The round was led by Backbone Ventures…
Read MoreActival Secures CHF 1.4 Million Innosuisse Grant
Actival, the Neuchâtel-Based medtech startup spun off from CSEM, has been awarded a CHF 1.4 million grant from Innosuisse to accelerate the development and market launch of its patented Active Splints — a new generation of patient-specific oral care devices developed in partnership with CSEM. The CHF 1.4 Million Innosuisse grant will support Actival in…
Read MoreData Startup Pitch
Apply before 31 August 2026 for the Data Startup Pitch, organised in collaboration between DatAfterwork, C Square Lab, TechFirm, Legaswiss and French Tech Switzerland. Are you developing a start-up in the field of data or artificial intelligence? Do you know of a promising team that deserves to be showcased? In partnership with DatAfterwork, C Square…
Read MoreGeneva AI Summit
The Geneva AI Summit is taking place from 21 to 22 June 2027 in Geneva. The event will bring the global conversation on artificial intelligence to the heart of multilateralism. For decades, Geneva has been a place where nations, international organizations, civil society, academia and the private sector have come together to address humanity’s most…
Read MoreUNDAE Opens Final Stage of Seed Funding Round
UNDAE, a University of Lausanne (UNIL) spinoff announces the opening of the final stage of its Seed funding round to a broader community of business angels and investors. UNDAE has developed a non-intrusive mattress topper fitted with pressure sensors. With medical-grade accuracy, it helps diagnose sleep disorders. By capturing the complexity of sleep over multiple…
Read MoreVolv Global Puts AI at the Heart of Rare Disease Diagnosis
Volv Global, healthcare AI company headquartered at Biopôle Épalinges (Vaud – Switzerland), has released two significant pieces of work in quick succession that together make a compelling case for rethinking how rare and hard-to-diagnose diseases are detected and funded. The first is a a retrospective case study applying machine learning to real-world EHR data conducted…
Read More10th Anniversary of the Center for Emerging Viral Diseases
The 10th Anniversary of the Center for Emerging Viral Diseases is taking place on 24 September 2026 at HUG in Geneva The Center for Emerging Viral Diseases is a joint institution of the Geneva University Hospitals (HUG) and the University of Geneva (UNIGE). Since its creation, the Center has established itself as a key player…
Read More